argenx SE | ARGX - Operating Expenses

Stock Price
703.60
Daily Change
-18.80 -2.60%
Monthly
0.80%
Yearly
16.72%
Q1 Forecast
704.56

argenx SE reported $776.99M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
AstraZeneca USD 12.53B 4.16B Dec/2025
Galapagos EUR 112.83M 9.48M Sep/2025
Genmab DKK 565M 38M Jun/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Qiagen NV USD 418.54M 23.25M Dec/2025
UCB EUR 2.36B 108M Dec/2024